The mRNA-1273.815 vaccine provided significant protection against COVID-19-related hospitalizations and medically attended COVID-19 among US adults.

I am writing to voice concerns over the findings of the phase 3 trial of the R21/Matrix-M malaria vaccine by Mehreen Datoo and colleagues.1 The study indicates that the vaccine's efficacy appears to ...

A population-based congenital cytomegalovirus screening program in Ontario successfully screened 551,034 newborns; of those completing assessment, 63 received valganciclovir treatment.

Wall Street is off to a volatile start in 2025, with investors stepping on the sell pedal after last week's jobs data, followed by a sharp about-face in sentiment following Wednesday's consumer ...

In a record-breaking span of just 11 months, Moderna created, developed, manufactured, and got regulatory authorization for mRNA-1273, a two-dose covid vaccine that is one of the first two mRNA ...

The single-arm, phase 2/3 study recruited participants aged 18 years or older who had received at least three doses of mRNA-1273 or BNT162b2 from 30 US centres. The coprimary endpoints were ...

Newborns born to mothers diagnosed with COVID-19 infection during pregnancy exhibited increased prevalence and risk for respiratory distress syndrome, highlighting the importance of effective ...

Melis­sa Moore helped ush­er in the first mR­NA med­i­cines, but the for­mer Mod­er­na ex­ec­u­tive thinks there’s still a lot of room for im­prove­ment.

But scientists at Moderna are in the late stages of testing what could be the first such shot, using mRNA technology against the virus. Here’s what to know about norovirus and where things stand ...

Craig Hoy, his party’s finance spokesman, said the probe had so far lasted 1,273 days. It came as he questioned SNP ministers in Holyrood over whether they knew the identities of the police ...